The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 16% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. Insiders have been net sellers over the past quarter.
Oceaneering International, Inc.
OII · the NYSE · USD · Market cap $3.4B · 11,100 employees
Oceaneering International, Inc.
PASS · Titan Ethical · score 70.0Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price33.30 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 16 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans to puts (put/call 12.33)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $27.00 to $34.63, base estimate $30.11 (screen dated 2026-11-19).
- Trend Distribution
- Insiders insiders sold, $264,971, latest filing 2026-11-02
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 12.33, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Oceaneering International, Inc. holds its Distribution at $33.30. Elevated stress, defensive posture warranted, held for 21 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 21 days |
| Price at the screen | $33.30 |
| Valuation | 10.43 trailing · 15.84 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.27 |
Five Screens: OII's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 32.74% | Below 33% | Pass |
| Interest-bearing cash | 0.26% | Below 33% | Pass |
| Receivables | 37.39% | Below 49% | Pass |
| Revenue purity | 0.52% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Oceaneering International, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OII's ethical verdict changes
Today OII passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades above our $30.11 fair value estimate, 5.60% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 10.6% above the base estimate.
Third-party analyst targets. The average target sits +31% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $30.11, with a range of $27.00 to $34.63, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 15.8xexpensive even after accounting for its growth |
| Trailing P/E | 10.4xreasonably valued |
| EPS, trailing | 3.28 |
| EPS, forward | 2.16 |
| Revenue growth | +5.6%slow but positive growth |
| Profit margin | 11.4%thin but positive margins |
| Return on equity | 30.8%an exceptional return on shareholder capital |
| FCF yield | 8.26% |
| Debt to equity | 0.65moderate, manageable leverage |
| Current ratio | 2.20comfortably covers its short-term bills |
| Beta | 1.27moves a little more than the market |
| Short interest, float | 0.09% |
| 52-week range | 22.77 - 54.25 |
| Market cap | $3.4B |
| Employees | 11,100 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 16% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. Insiders have been net sellers over the past quarter.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 13.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 31% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (4 analysts) rates it none, with a mean price target of $35. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Core Natural Resources, Bristow Group, CVR Energy, Baker Hughes, and Oceaneering shares plummet, what you need to know Yahoo Finance · 12d ago
- Oceaneering International (OII) Stock Sees Fair Value Cut After Split Analyst Revisions Yahoo Finance · 12d ago
- Oceaneering International Eyes New Opportunities in Offshore Markets Yahoo Finance · 18d ago
- Oceaneering: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 21d ago
- What Just Happened To TechnipFMC Stock? Yahoo Finance · 21d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-02 | Larson Roderick A. | Pres, CEO | S - Sale | 6,000 | $264,971 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $37.93 | +3.5% | · | $1,035 | +3.5% |
| 2 months | $36.20 | +8.5% | · | $1,085 | +8.5% |
| 3 months | $35.44 | +10.8% | · | $1,108 | +10.8% |
| 6 months | $26.65 | +47.4% | · | $1,474 | +47.4% |
| 1 year | $20.72 | +89.5% | · | $1,895 | +89.5% |
| 2 years | $21.57 | +82.1% | · | $1,821 | +82.1% |
| 3 years | $17.81 | +120.5% | · | $2,205 | +120.5% |
| 5 years | $16.88 | +132.6% | · | $2,326 | +132.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever OII does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.